This article was originally published in The Tan Sheet
Pfizer Senior VP-Strategic Planning & Business Development Tom Booth will lead Consumer Healthcare division's transition team in the Pharmacia integration. Teams are responsible for "day-to-day transition planning process," serving as "focal point for two-way communication between the divisions and corporate and between the divisions themselves," says 1Pfizer employee newsletter article filed with SEC. Pfizer, Pharmacia team leaders will meet for first time Aug. 13. "Transition process will be carried out using Pfizer's existing governance structure, which went through a significant overhaul following the W-L merger, with more decision-making authority and accountability being given to the businesses," Pfizer says. Companies expect deal to close by year-end (2"The Tan Sheet" July 22, 2002, p. 8)...
You may also be interested in...
Pfizer's acquisition of Pharmacia likely will draw antitrust regulatory scrutiny to one of the combined firm's smallest product lines - OTC motion sickness tablets
CEO Werner Baumann admits he was skeptical at first as to whether the German group had the necessary know-how to manufacture vaccines but the firm's expertise in the development of biotech products has strengthened his belief Bayer can deliver.
As part of its big data initiative, the European Medicines Agency is supporting projects that will help identify appropriate real-world data sources for regulatory decision making.